Log In
Print this Print this

GDF-8 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Rigel Pharmaceuticals Inc.
DescriptionGDF-8 inhibitor
Molecular Target Myostatin (MSTN) (GDF8)
Mechanism of ActionMyostatin (GDF-8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular atrophy
Indication DetailsTreat muscular atrophy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today